Buspirone for the Treatment of Traumatic Brain Injury (TBI) Irritability and Aggression

PHASE4RecruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

May 15, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Traumatic Brain Injury
Interventions
DRUG

Buspirone

Buspirone/placebo will be given in increasing increments of 15 mg as needed. Subjects will start with 15 mg on day one and end with 60 mg on day 91 or placebo equivalent. Dose is titrated based on treatment response.

DRUG

Placebo

The placebo tablets taste and look identical to buspirone.

Trial Locations (1)

46254

RECRUITING

Indiana University and Rehabilitation Hospital of Indiana, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER